Alcohol intake and mortality among women with invasive breast cancer
British Journal of Cancer,  Clinical Article

H R Harris et al. –These findings suggest that alcohol intake up to approximately one small drink per day does not negatively impact breast cancer–specific survival and a half drink per day is associated with a decreased risk of mortality from other causes.


  • Investigated whether alcohol intake was associated with survival among 3146 women diagnosed with invasive breast cancer in the Swedish Mammography Cohort
  • Alcohol consumption was estimated using food frequency questionnaire
  • Cox proportional hazard models were used to calculate HRs and 95% CIs


  • From 1987 to 2008 there were 385 breast cancer–specific deaths and 860 total deaths
  • No significant association was observed between alcohol intake and breast cancer–specific survival
  • Women who consumed 10?g per day (corresponding to approximately 0.75 to 1 drinks) or more of alcohol had an adjusted HR (95% CI) of breast cancer–specific death of 1.36 (0.82–2.26;ptrend=0.47) compared with non–drinkers
  • Significant inverse association was observed between alcohol and non–breast cancer deaths
  • Those who consumed 3.4–9.9?g per day of alcohol had a 33% lower risk of death compared with non–drinkers (95% CI 0.50–0.90;ptrend=0.04)

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Oncology Articles

1 Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response The Lancet Oncology, August 19, 2014    Clinical Article

2 Survival outcome and reduction rate of Ki-67 between pre- and post-neoadjuvant chemotherapy in breast cancer patients with non-pCR Breast Cancer Research and Treatment, August 12, 2014    Clinical Article

3 Effect of obesity on aromatase inhibitor efficacy in postmenopausal, hormone receptor-positive breast cancer: A systematic review Breast Cancer Research and Treatment, August 15, 2014    Review Article

4 Prognosis of synchronous bilateral breast cancer: a review and meta-analysis of observational studies Breast Cancer Research and Treatment, August 1, 2014    Evidence Based Medicine    Review Article

5 Management of sentinel node re-mapping in patients who have second or recurrent breast cancer and had previous axillary procedures Full Text World Journal of Surgical Oncology, August 4, 2014    Free full text    Clinical Article

6 Outcome of triple negative breast cancer: comparison of sporadic and BRCA1-associated cancers Breast Cancer Research and Treatment, July 8, 2014    Clinical Article

7 Pertuzumab in combination with trastuzumab and docetaxel for the treatment of HER2-positive metastatic or locally recurrent unresectable breast cancer PharmacoEconomics, August 21, 2014    Review Article

8 Postoperative tamoxifen for ductal carcinoma in situ: Cochrane systematic review and meta-analysis The Breast, August 1, 2014    Evidence Based Medicine    Review Article

9 Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): Follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort The Lancet Oncology, March 24, 2014    Clinical Article

10 Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers Full Text BMC Cancer, August 22, 2014    Free full text    Clinical Article

11 Is elective nodal irradiation beneficial in patients with pathologically negative lymph nodes after neoadjuvant chemotherapy and breast-conserving surgery for clinical stage II–III breast cancer? A multicentre retrospective study (KROG 12-05) British Journal of Cancer, February 6, 2014    Clinical Article

12 Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance) Journal of Clinical Oncology, August 8, 2014    Clinical Article

13 Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial Full Text BMC Cancer, August 5, 2014    Free full text    Clinical Article

14 The efficacy of molecular subtyping in predicting postoperative recurrence in breast-conserving therapy: a 15-study meta-analysis Full Text World Journal of Surgical Oncology, July 18, 2014    Free full text

15 A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: An analysis of the ATHENA trial The Breast, August 14, 2014    Evidence Based Medicine    Clinical Article

16 The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes Anti-Cancer Drugs, August 19, 2014    Clinical Article

17 A phase I study of combination therapy with nanoparticle albumin-bound paclitaxel and cyclophosphamide in patients with metastatic or recurrent breast cancer International Journal of Clinical Oncology, August 8, 2014    Clinical Article

18 Meta-analysis of black tea consumption and breast cancer risk: update 2013 Nutrition and Cancer, August 6, 2014    Evidence Based Medicine

19 The extent of extracapsular extension may influence the need for axillary lymph node dissection in patients with T1-T2 breast cancer Annals of Surgical Oncology, August 20, 2014    Clinical Article

20 Preoperative MRI in patients with locoregional recurrent breast cancer Academic Radiology, August 26, 2014    Clinical Article

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncologymore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More